{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:17:21Z","timestamp":1773253041675,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.amjms.2017.04.009","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T21:17:25Z","timestamp":1492031845000},"page":"568-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fenofibrate Attenuates Hypertension in Goldblatt Hypertensive Rats: Role of 20-Hydroxyeicosatetraenoic Acid in the Nonclipped Kidney"],"prefix":"10.1016","volume":"353","author":[{"given":"Alexandra","family":"Sporkov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u011bra","family":"\u010cert\u00edkov\u00e1 Ch\u00e1bov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0160\u00e1rka","family":"Dole\u017eelov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0160\u00e1rka","family":"J\u00edchov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libor","family":"Kopkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zde\u0148ka","family":"Va\u0148ourkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elzbieta","family":"Kompanowska-Jezierska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Maxov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lud\u011bk","family":"\u010cervenka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2017.04.009_bib1","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/HJH.0b013e328364ca4c","article-title":"2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH\/ESC Task Force for the Management of Arterial Hypertension","volume":"31","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjms.2017.04.009_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0025-6196(11)64210-9","article-title":"Outcomes of atherosclerotic renal artery stenosis managed without revascularization","volume":"75","author":"Ch\u00e1bov\u00e1","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjms.2017.04.009_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MNH.0000000000000202","article-title":"Renal artery stenosis: if and when to intervene","volume":"25","author":"Textor","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.amjms.2017.04.009_bib4","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2215\/CJN.10491015","article-title":"Effects of stenting for atherosclerotic renal artery stenosis on eGFR and predictors of clinical events in the CORAL trial","volume":"11","author":"Tuttle","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjms.2017.04.009_bib5","first-page":"F131","article-title":"Angiotensin-dependent renal mechanism in two-kidney, one-clip renal vascular hypertension","volume":"245","author":"Ploth","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib6","first-page":"170","article-title":"Unraveling the mystery of Goldblatt hypertension","volume":"13","author":"Navar","year":"1998","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.amjms.2017.04.009_bib7","series-title":"Hypertension: Pathophysiology, Diagnosis and Management","first-page":"1437","article-title":"Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension","author":"Mitchell","year":"1990"},{"key":"10.1016\/j.amjms.2017.04.009_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1556\/APhysiol.94.2007.1-2.5","article-title":"Intrarenal renin-angiotensin system and counteracting protective mechanisms in angiotensin II-dependent hypertension","volume":"94","author":"Mitchell","year":"2007","journal-title":"Acta Physiol Hung"},{"key":"10.1016\/j.amjms.2017.04.009_bib9","series-title":"Seldin and Giebisch\u05f3s the Kidney: Physiology and Pathophysiology","first-page":"1319","article-title":"Physiology and pathophysiology of hypertension","author":"Hall","year":"2013"},{"key":"10.1016\/j.amjms.2017.04.009_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.HYP.20.6.763","article-title":"Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one-clip hypertensive rats","volume":"20","author":"Guan","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.amjms.2017.04.009_bib11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ajh\/6.11.914","article-title":"Renin, angiotensinogen, and kallikrein gene expression in two-kidney Goldblatt hypertensive rats","volume":"6","author":"El-Dahr","year":"1993","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.amjms.2017.04.009_bib12","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1097\/HJH.0b013e32832f0d06","article-title":"Impairment of angiotensin-converting 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension","volume":"27","author":"B\u00fcrgelov\u00e1","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjms.2017.04.009_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/01.HYP.33.1.102","article-title":"Proximal tubular angiotensin II levels and renal functional responses to receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats","volume":"33","author":"\u010cervenka","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.amjms.2017.04.009_bib14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/01.HYP.0000036452.28493.74","article-title":"Essentials role of AT1A receptor in the development of 2K1C Hypertension","volume":"40","author":"\u010cervenka","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.amjms.2017.04.009_bib15","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/00004872-200308000-00018","article-title":"Genetic inactivation of the B2 receptor mice worsens two-kidney, one-clip hypertension: role of NO and the AT2 receptor","volume":"21","author":"\u010cervenka","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjms.2017.04.009_bib16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/HJH.0b013e3282fe6eaa","article-title":"Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice","volume":"26","author":"\u010cervenka","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjms.2017.04.009_bib17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000320689","article-title":"Knockout of angiotensin 1-7 receptor mas worsens the course of two-kidney, one-clip Goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II","volume":"33","author":"Raku\u0161an","year":"2010","journal-title":"Kidney and Blood Press Res"},{"key":"10.1016\/j.amjms.2017.04.009_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000339883","article-title":"Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension","volume":"35","author":"Kopkan","year":"2012","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.amjms.2017.04.009_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/HJH.0b013e328334dfd4","article-title":"Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats","volume":"28","author":"Walkowska","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjms.2017.04.009_bib20","series-title":"Hypertension: Pathophysiology, Diagnosis and Management","first-page":"1029","article-title":"The dominant role of the kidneys in the long term regulation of arterial pressure in normal and hypertensive states","author":"Guyton","year":"1990"},{"key":"10.1016\/j.amjms.2017.04.009_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00041552-199601000-00012","article-title":"Interactions between arterial pressure and sodium excretion","volume":"5","author":"Navar","year":"1996","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.amjms.2017.04.009_bib22","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.1996.03530440061038","article-title":"The role of the kidney in hypertension","volume":"275","author":"Cowley","year":"1996","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.amjms.2017.04.009_bib23","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1172\/JCI72274","article-title":"The inextricable role of the kidney in hypertension","volume":"124","author":"Crowley","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjms.2017.04.009_bib24","first-page":"R217","article-title":"Role of the kidney in the pathogenesis of hypertension: time for a neo-Guyton paradigm or a paradigm shift?","volume":"310","author":"Evans","year":"2016","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib25","first-page":"F749","article-title":"Reciprocal changes in renal ACE\/ANG II and ACE2\/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats","volume":"300","author":"Prieto","year":"2011","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib26","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.HYP.25.6.1232","article-title":"Modulation of tubuloglomerular feedback by angiotensin II type 1 receptors during the development of Goldblatt hypertension","volume":"25","author":"Braam","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.amjms.2017.04.009_bib27","first-page":"F553","article-title":"Angiotensin-mediated alterations in nephron function in Goldblatt hypertensive rats","volume":"243","author":"Huang","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/FJC.0b013e3181f04b1c","article-title":"20-Hydroxyeicosatetraenoic acid: a new target for the treatment of hypertension","volume":"56","author":"Williams","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.amjms.2017.04.009_bib29","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/pr.113.007781","article-title":"The pharmacology of the cytochrome P450 epoxygenase\/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease","volume":"66","author":"Fleming","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.amjms.2017.04.009_bib30","first-page":"R321","article-title":"Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease","volume":"302","author":"Elmarakby","year":"2012","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib31","first-page":"1427","article-title":"Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology","volume":"21","author":"Fan","year":"2016"},{"key":"10.1016\/j.amjms.2017.04.009_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2015.03.002","article-title":"Vascular actions of 20-HETE","volume":"120","author":"Hoopes","year":"2015","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"10.1016\/j.amjms.2017.04.009_bib33","first-page":"F274","article-title":"Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways","volume":"273","author":"Imig","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00004872-200105000-00020","article-title":"Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid","volume":"19","author":"Imig","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjms.2017.04.009_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-201X.2000.00638.x","article-title":"Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole","volume":"168","author":"Kohagure","year":"2000","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.amjms.2017.04.009_bib36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1291\/hypres.24.551","article-title":"Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles","volume":"24","author":"Kohagure","year":"2001","journal-title":"Hypertens Res"},{"key":"10.1016\/j.amjms.2017.04.009_bib37","first-page":"R60","article-title":"Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II","volume":"283","author":"Alonso-Galicia","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib38","first-page":"R977","article-title":"Increased renal vascular reactivity to angiotensin II after unilateral nephrectomy in the rat involves 20-HETE","volume":"291","author":"Joly","year":"2006","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib39","first-page":"R1468","article-title":"Role of cytochrome P450 metabolites in the regulation of renal function and blood pressure in 2-kidney, 1-clip hypertensive rats","volume":"300","author":"Sporkov\u00e1","year":"2011","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vph.2015.08.013","article-title":"Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats","volume":"73","author":"Al\u00e1nov\u00e1","year":"2015","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.amjms.2017.04.009_bib41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.amjms.2016.02.030","article-title":"Interlobular arteries from 2-kidney, 1-clip Goldblatt hypertensive rats exhibit impaired vasodilator response to epoxyeicosatrienoic acids","volume":"351","author":"Sporkov\u00e1","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjms.2017.04.009_bib42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.amjms.2016.09.008","article-title":"Fenofibrate attenuates malignant hypertension by suppression of the renin-angiotensin system: a study in Cyp1a1-Ren-2 transgenic rats","volume":"352","author":"J\u00edchov\u00e1","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjms.2017.04.009_bib43","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1210\/endo.142.10.8458","article-title":"Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding","volume":"142","author":"Escher","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.amjms.2017.04.009_bib44","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1097\/01.ASN.0000139067.83419.46","article-title":"Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome","volume":"15","author":"Guan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjms.2017.04.009_bib45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/bj3060473","article-title":"Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription","volume":"306","author":"Aldridge","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.amjms.2017.04.009_bib46","doi-asserted-by":"crossref","first-page":"19051","DOI":"10.1016\/S0021-9258(18)41738-3","article-title":"The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid","volume":"267","author":"Muerhoff","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.amjms.2017.04.009_bib47","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/ki.2008.300","article-title":"Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension","volume":"74","author":"Zhou","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjms.2017.04.009_bib48","first-page":"H2187","article-title":"PPAR-alpha activator fenofibrate increases renal CYP-derived eicosanoids synthesis and improves endothelial dilator function in obese Zuckar rats","volume":"290","author":"Zhao","year":"2006","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib49","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9440(10)63142-2","article-title":"A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury","volume":"164","author":"Muller","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.amjms.2017.04.009_bib50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease\u2014a 30th anniversary update","volume":"219","author":"Vanhoutte","year":"2017","journal-title":"Acta Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/bs.apha.2016.04.003","article-title":"Epoxyeicosatrienoic acids and 20-hydroxyeicosatrienoic acid on endothelial and vascular function","volume":"77","author":"Imig","year":"2016","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.amjms.2017.04.009_bib52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.HYP.31.1.225","article-title":"Effects of lipid-lowering agents in the Dahl salt-sensitive rat","volume":"31","author":"Wilson","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.amjms.2017.04.009_bib53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1139\/y99-149","article-title":"Fenofibrate lowers blood pressure in two genetic models of hypertension","volume":"78","author":"Shatara","year":"2000","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.amjms.2017.04.009_bib54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000092981","article-title":"Effects of anaesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats","volume":"29","author":"Huskov\u00e1","year":"2006","journal-title":"Kidney Blood Res"},{"key":"10.1016\/j.amjms.2017.04.009_bib55","first-page":"F902","article-title":"Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats","volume":"262","author":"Fox","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/pr.59.3.3","article-title":"The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease","volume":"59","author":"Kobori","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.amjms.2017.04.009_bib57","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/1440-1681.12419","article-title":"Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula","volume":"42","author":"\u010cervenka","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib58","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/1440-1681.12310","article-title":"Different mechanisms of acute versus long term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats","volume":"41","author":"Sporkov\u00e1","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib59","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/1440-1681.12553","article-title":"Intrarenal alterations of the angiotensin-converting type 2\/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats","volume":"43","author":"Huskov\u00e1","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/01.HYP.0000150857.39919.cb","article-title":"Recommendations for blood pressure measurements in humans and experimental animals. Part 2: blood pressure measurements in experimental animals","volume":"45","author":"Kurtz","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.amjms.2017.04.009_bib61","first-page":"F949","article-title":"Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport","volume":"278","author":"Quigley","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib62","doi-asserted-by":"crossref","first-page":"C1775","DOI":"10.1152\/ajpcell.1994.266.6.C1775","article-title":"Cytochrome P-450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb","volume":"266","author":"Escalante","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib63","first-page":"R2400","article-title":"Effects of 20-HETE on Na+-K+-ATPase activity in the thick ascending loop of Henle","volume":"292","author":"Yu","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib64","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.HYP.0000084634.97353.1A","article-title":"Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats","volume":"42","author":"Hoagland","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.amjms.2017.04.009_bib65","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/PL00000897","article-title":"Cytochrome P450 and metabolism of xenobiotics","volume":"58","author":"Anzenbacher","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.amjms.2017.04.009_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2016.1257021","article-title":"Microsomal cytochrome P450 as a target for drug discovery and repurposing","volume":"49","author":"El Sherbeni","year":"2017","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.amjms.2017.04.009_bib67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/bbrc.2001.5167","article-title":"The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation","volume":"285","author":"Capdevila","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.amjms.2017.04.009_bib68","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00424-010-0804-6","article-title":"Epoxyeicosatrienoic acids and endothelium-dependent responses","volume":"459","author":"Campbell","year":"2010","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.amjms.2017.04.009_bib69","first-page":"R1055","article-title":"Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension","volume":"284","author":"Nakagawa","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjms.2017.04.009_bib70","first-page":"F71","article-title":"20-HETE and CYP4A2 \u03c9-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats","volume":"311","author":"Dalmasso","year":"2016","journal-title":"Am J Physiol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296291730215X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296291730215X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T12:59:50Z","timestamp":1658926790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296291730215X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S000296291730215X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2017.04.009","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenofibrate Attenuates Hypertension in Goldblatt Hypertensive Rats: Role of 20-Hydroxyeicosatetraenoic Acid in the Nonclipped Kidney","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2017.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}